OUR JOURNEY

Matt Hedrick, B.S., MBA

​

Most recently the 15-year CEO of Nanovis overseeing all aspects from technology acquisition, development, differentiation, commercialization and divestiture whose tenure culminated in a signed letter of intent to divest Nanovis' lead nanotechnology to Medtronic. 

​

Previously Mr. Hedrick performed with distinction in marketing and sales management for a combined 19 years at Eli Lilly and Company, and Parke-Davis (now Pfizer). Education includes a B.S. in microbiology from the University of Illinois and an MBA from Northwestern's Kellogg school.

Robert Bacallao MD FACP, FASN

​​

Emeritus Professor of Medicine, Indiana University

Adjunct Professor of Biomedical Engineering, Purdue University

BS Biomedical Engineering Science, Northwestern University

Prior Faculty Appointments at the 

UCLA David Geffen School of Medicine and the Northwestern Feinberg School of Medicine

​

Dr. Bacallao invented RESTARI's treatment for acute kidney injury, kidney specific gene delivery, and treatments for PKD as well as discovering the proteins cablin and eliosin.

​

30 plus years in clinical nephrology

Pioneered the use of advanced light microscopy methods in renal research

Former director of the gene and probe delivery core at the Indiana Center of Biological Microscopy.  The center is a recipient of an NIH funded O’Brien Center of Excellence

 

Holder of four US patents, 82 peer reviewed publications

John Timko, M.S., M.B.A

​

Over three decades of medical device experience with products and companies delivering solutions to Interventional Cardiology, Interventional Radiology, Radiology, renal, biopsy and related care providers.  Executive roles have centered on sales force construction, marketing, product development, strategy and business development.  Holder of multiple device patents that have led to commercialized products that have generated hundreds of millions of dollars in sales revenue.  Founder and CEO of The Device Hub, a private entity focused on medical device distribution, product design and development.  Most recent corporate role included positions of VP of Sales and Marketing, VP Product Development and VP of Strategy and Business Development.

Eric Flachbart, BEng

​

Over three decades of pump development, manufacturing, and company leadership, including serving as the CEO of Infusion Analytics, and Vice President of Byonycks, President of Numia, and time at Bard provides Eric the world leading expertise to guide Restari's pump development.

Dirk Hoyns

​

Over three decades of experience including extensive biopsy device and catheter design gathered as the President of Device Technologies, Advanced Catheter Technologies, and Bard